BGMSP
Bio Green Med Solution, Inc.
OTC Markets OTCPKUSDEQUITY
Industrials
DELAYED
Last price
3.04
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
3.04
Day high
2.76
Day low
2.69
Volume
200
Market cap
—
P/E (TTM)
—
52W range
0.30 – 14.00
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-1.32%
+0.1%
1M
-14.29%
-18.0%
3M
+197.03%
+193.9%
6M
-3.23%
-14.3%
YTD
-24.81%
-37.1%
1Y
-44.65%
-64.6%
3Y
-84.17%
-158.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value$13.01M
Revenue (TTM)$1.86M
Gross profit$-388.00K
EBITDA$-3.55M
Net income$-9.19M
EPS (TTM)—
Free cash flow—
Total cash$3.79M
Total debt$0
Book value / share$1.28
Shares outstanding—
Float4.27M
Short % of float—
Dividend yield20.00%
Beta (5Y)-0.40
Short interest
Shares short
0
Prior 0
Change vs prior
—
—
% of float
—
—
% of shares out
—
Against total outstanding
Days to cover
0.0
Liquid
Float
4.27M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book2.38
EV / revenue6.99
EV / EBITDA-3.66
Gross margin-20.85%
Operating margin-124.41%
Profit margin-118.27%
Return on equity35.66%
Return on assets-36.31%
Debt / equity—
Current ratio8.63
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $747.00K | $43.00K | $420.00K | $0 | — | +1,637.2% |
| Operating revenue | $747.00K | $43.00K | $420.00K | $0 | — | +1,637.2% |
| Cost of revenue | $609.00K | $0 | — | — | — | — |
| Gross profit | $138.00K | $43.00K | — | — | — | +220.9% |
| Research & development | $848.00K | $6.66M | $19.16M | $20.27M | — | -87.3% |
| Selling, general & admin | $7.72M | $5.39M | $6.72M | $7.38M | — | +43.1% |
| Total operating expense | $8.56M | $12.05M | $25.87M | $27.66M | — | -28.9% |
| Operating income | -$8.43M | -$12.00M | -$25.45M | -$27.66M | — | +29.8% |
| Net interest income | $62.00K | $12.00K | $266.00K | $210.00K | — | +416.7% |
| Pre-tax income | -$2.99M | -$11.99M | -$25.55M | -$25.91M | — | +75.1% |
| Tax provision | $7.00K | -$782.00K | -$3.00M | -$4.72M | — | +100.9% |
| Net income | — | — | — | — | -$18.46M | — |
| Net income to common | -$14.09M | -$11.21M | -$22.76M | -$21.40M | — | -25.7% |
| EBIT | -$8.43M | -$12.00M | -$25.45M | -$27.66M | — | +29.8% |
| EBITDA | -$8.42M | -$12.00M | -$25.42M | -$27.62M | — | +29.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $3.50M | $3.14M | $3.38M | $18.34M | +11.7% |
| Cash & short-term investments | $3.50M | $3.14M | $3.38M | $18.34M | +11.7% |
| Accounts receivable | $1.26M | $0 | — | — | — |
| Inventory | $1.38M | $0 | — | — | — |
| Total current assets | $6.26M | $3.67M | $7.44M | $24.41M | +70.3% |
| Property, plant & equipment | $149.00K | $7.00K | $102.00K | $174.00K | +2,028.6% |
| Goodwill & intangibles | $1.57M | $0 | — | — | — |
| Total assets | $8.19M | $4.09M | $8.80M | $28.05M | +99.9% |
| Total current liabilities | $1.33M | $6.27M | $8.16M | $7.51M | -78.7% |
| Total debt | $2.00K | $0 | $37.00K | $106.00K | — |
| Total liabilities | $1.34M | $6.27M | $8.20M | $7.62M | -78.6% |
| Retained earnings | -$454.41M | -$439.49M | -$428.28M | -$405.73M | -3.4% |
| Shareholder equity | $6.84M | -$2.17M | $607.00K | $20.43M | +414.7% |
| Working capital | $4.92M | -$2.59M | -$717.00K | $16.90M | +289.8% |
| Net tangible assets | $5.27M | -$2.17M | $607.00K | $20.43M | +342.5% |
| Shares issued | 5.40M | 36.91K | 4.41K | 3.48K | +14,529.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$3.00M | -$11.21M | -$22.55M | -$21.20M | — | +73.3% |
| Depreciation & amortisation | $5.00K | $6.00K | $31.00K | $32.00K | — | -16.7% |
| Stock-based compensation | $2.33M | $592.00K | $1.47M | $1.51M | — | +294.3% |
| Change in working capital | -$9.06M | $2.66M | $5.01M | -$1.17M | — | -440.5% |
| Operating cash flow | -$4.77M | -$7.99M | -$16.11M | -$20.83M | — | +40.3% |
| Capital expenditure | — | — | -$6.00K | -$7.00K | -$27.00K | — |
| Investing cash flow | $0 | $0 | -$6.00K | -$7.00K | — | — |
| Dividends paid | -$61.00K | $0 | -$201.00K | -$201.00K | — | — |
| Financing cash flow | $5.26M | $7.82M | $848.00K | $3.00M | — | -32.7% |
| Free cash flow | -$4.77M | -$7.99M | -$16.12M | -$20.83M | — | +40.3% |
| End cash position | $3.50M | $3.14M | $3.38M | $18.34M | — | +11.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $778.00K | $666.00K | $81.00K | $0 | $0 | — | +16.8% |
| Operating revenue | $778.00K | $666.00K | $81.00K | $0 | $0 | — | +16.8% |
| Cost of revenue | $635.00K | $545.00K | $64.00K | — | $0 | — | +16.5% |
| Gross profit | $143.00K | $121.00K | $17.00K | — | $0 | — | +18.2% |
| Research & development | — | -$47.00K | $5.00K | $68.00K | $822.00K | $880.00K | — |
| Selling, general & admin | $389.00K | $1.25M | $1.00M | $1.25M | $4.21M | — | -68.9% |
| Total operating expense | $389.00K | $1.20M | $1.01M | $1.32M | $4.21M | — | -67.7% |
| Operating income | -$246.00K | -$1.08M | -$992.00K | -$1.32M | -$4.21M | — | +77.3% |
| Net interest income | $9.00K | $45.00K | $9.00K | $2.00K | $6.00K | — | -80.0% |
| Pre-tax income | -$167.00K | -$606.00K | -$988.00K | -$1.32M | -$4.21M | — | +72.4% |
| Tax provision | $30.00K | $5.00K | $0 | $2.00K | $0 | — | +500.0% |
| Net income | -$197.00K | -$611.00K | -$988.00K | -$1.32M | -$81.00K | — | +67.8% |
| Net income to common | -$217.00K | -$10.17M | -$2.50M | -$1.34M | -$81.00K | — | +97.9% |
| EBIT | -$246.00K | -$1.08M | -$992.00K | -$1.32M | -$4.21M | — | +77.3% |
| EBITDA | -$245.00K | -$1.08M | -$992.00K | -$1.32M | -$4.21M | — | +77.3% |
One period below is a stub at the data source — the figures were never populated. Those cells read n/r rather than $0, because zero is not what was reported.
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 stub | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.34M | $3.50M | $3.84M | $4.28M | $3.45M | — | -4.7% |
| Cash & short-term investments | $3.34M | $3.50M | $3.84M | $4.28M | $3.45M | — | -4.7% |
| Accounts receivable | $1.19M | $1.26M | $725.00K | — | — | n/r | -5.5% |
| Inventory | $947.00K | $1.38M | $1.37M | — | — | n/r | -31.6% |
| Total current assets | $5.62M | $6.26M | $6.44M | $4.38M | $3.71M | — | -10.1% |
| Property, plant & equipment | $148.00K | $149.00K | $144.00K | $18.00K | $20.00K | — | -0.7% |
| Goodwill & intangibles | $1.57M | $1.57M | $1.57M | — | — | n/r | 0.0% |
| Total assets | $7.56M | $8.19M | $8.16M | $4.40M | $3.73M | — | -7.6% |
| Total current liabilities | $796.00K | $1.33M | $1.00M | $760.00K | $663.00K | — | -40.2% |
| Total debt | $0 | $2.00K | $5.00K | $10.00K | $9.00K | — | -100.0% |
| Total liabilities | $804.00K | $1.34M | $1.06M | $770.00K | $672.00K | — | -40.1% |
| Retained earnings | -$454.61M | -$454.41M | -$444.26M | -$441.78M | -$440.46M | — | -0.0% |
| Shareholder equity | $6.76M | $6.84M | $7.10M | $3.63M | $3.06M | — | -1.2% |
| Working capital | $4.83M | $4.92M | $5.44M | $3.62M | $3.05M | — | -2.0% |
| Net tangible assets | $5.19M | $5.27M | $5.53M | $3.63M | $3.06M | — | -1.6% |
| Shares issued | 5.52M | 5.40M | 3.50M | 1.58M | 863.90K | — | +2.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$197.00K | -$611.00K | -$988.00K | -$1.32M | -$81.00K | +67.8% |
| Depreciation & amortisation | $1.00K | $4.00K | $0 | $1.00K | $0 | -75.0% |
| Stock-based compensation | $1.00K | $655.00K | $6.00K | $7.00K | $1.67M | -99.8% |
| Change in working capital | -$81.00K | -$83.00K | $558.00K | -$4.69M | -$4.84M | +2.4% |
| Operating cash flow | -$278.00K | -$33.00K | -$434.00K | -$1.06M | -$3.25M | -742.4% |
| Capital expenditure | -$1.00K | — | — | — | — | — |
| Investing cash flow | -$1.00K | $0 | $0 | $0 | $0 | — |
| Dividends paid | -$20.00K | -$20.00K | $0 | -$41.00K | $0 | 0.0% |
| Financing cash flow | $105.00K | -$259.00K | -$3.00K | $1.88M | $3.65M | +140.5% |
| Free cash flow | -$279.00K | -$33.00K | -$434.00K | -$1.06M | -$3.25M | -745.5% |
| End cash position | $3.34M | $3.50M | $3.84M | $4.28M | $3.45M | -4.7% |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions1.39%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.04
+0.13% from price
SMA 20
2.92
+2.61% from price
SMA 50
2.02
+48.27% from price
SMA 100
1.49
+104.32% from price
SMA 200
2.57
+16.91% from price
EMA 12
2.98
+1.94% from price
EMA 26
2.72
+11.63% from price
EMA 50
2.31
+31.33% from price
RSI (14)
63.4
Neutral
MACD (12,26,9)
0.26
Hist -0.06
ATR (14)
0.02
0.58% of price
Realised vol 30D
235.3%
Annualised
Bollinger upper
3.23
20, 2σ
Bollinger lower
2.62
20, 2σ
50 / 200 cross
Death
2.02 vs 2.57
Trend bias
Above 200
+16.91%
Risk profile
Beta vs SPY
1.52
More volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
235.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-95.8%
Peak to trough
Max drawdown 5Y
-98.6%
Peak to trough
ATR 14
0.02
0.58% of price
Beta (reported)
-0.40
5Y monthly, from filing
Dividends & splits
Forward rate$0.60 / yr
Forward yield20.00%
5-year avg yield6.72%
Payout ratio—
Ex-dividend dateJul 23, 2026
Next pay dateMay 1, 2026
Last split1:15
Split dateJul 7, 2025
Headlines
BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
GlobeNewswire · 10d ago
Top Premarket Gainers
MT Newswires · 78d ago
Bio Green Med Solution Enters Business Combination Agreement to Acquire Future NRG
MT Newswires · 79d ago
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
GlobeNewswire · 79d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.